Company Overview and News

to your dashboard

Headline News

LifeSci Capital Initiates Coverage of Biophytis SA

2016-01-20 accesswire
NEW YORK, NY / ACCESSWIRE / January 20, 2016 / LifeSci Capital, LLC, a research-driven investment bank with deep domain expertise in the life sciences sector, today announced that it has initiated coverage of Biophytis (Euronext Paris: ALBPS.PA), a clinical-stage biopharmaceutical company developing therapies for age-related diseases. The Company is developing Sarcob, an agonist of the Angiotensin 1-7 receptor MAS, for the treatment of sarcopenic obesity.